INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 128 filers reported holding INOVIO PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.09 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $63,626 | +73033.3% | 163,562 | -16.5% | 0.00% | -20.0% |
| Q2 2023 | $87 | -72.2% | 195,853 | -48.8% | 0.01% | -73.7% |
| Q1 2023 | $313 | -48.9% | 382,158 | -2.8% | 0.02% | -50.0% |
| Q4 2022 | $613 | -99.9% | 393,164 | +11.5% | 0.04% | -5.0% |
| Q3 2022 | $608,000 | -2.7% | 352,721 | -2.3% | 0.04% | +2.6% |
| Q2 2022 | $625,000 | -49.6% | 361,196 | +4.5% | 0.04% | -40.9% |
| Q1 2022 | $1,241,000 | -9.5% | 345,567 | +25.8% | 0.07% | -1.5% |
| Q4 2021 | $1,371,000 | +19.1% | 274,703 | +70.8% | 0.07% | +11.7% |
| Q3 2021 | $1,151,000 | +17.3% | 160,821 | +52.0% | 0.06% | +15.4% |
| Q2 2021 | $981,000 | – | 105,779 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON ASSOCIATES LP | 784,679 | $643,437 | 0.10% |
| Green Alpha Advisors, LLC | 146,300 | $119,966 | 0.08% |
| Virtus ETF Advisers LLC | 54,106 | $44,367 | 0.02% |
| Cedar Brook Financial Partners, LLC | 104,881 | $86,002 | 0.02% |
| PROFUND ADVISORS LLC | 418,749 | $343,374 | 0.02% |
| Arlington Capital Management, Inc. | 27,735 | $22,743 | 0.02% |
| Hennion & Walsh Asset Management, Inc. | 382,158 | $313 | 0.02% |
| Rafferty Asset Management, LLC | 2,647,927 | $2,171,300 | 0.02% |
| Brainard Capital Management LLC | 16,666 | $13,666 | 0.01% |
| Beck Bode, LLC | 41,218 | $33,799 | 0.01% |